The US Supreme Court has struck down a part of the bankruptcy deal for Purdue Pharma that would have shielded members of the Sackler family from future lawsuits over their role in fueling the opioid crisis.
Global growth in the pharma market will reach 7.7 percent through to the end of the decade, according to an analysis from industry commentator Evaluate. The London-based firm has released its 2024 World Preview Report, which suggests that worldwide prescription drug sales could reach $1.7 trillion by 2030.
At least 11 of the 17 members of the UK government’s Scientific Advisory Committee on Nutrition have conflicts of interest with the likes of Nestle, sugar manufacturer Tate and Lyle, and the world’s largest ice cream producer, Unilever, reports Sophie Borland in the British Medical Journal.
The Sackler family, which owns the OxyContin maker Purdue Pharma, has agreed to pay up to $7.4 billion in a settlement to lawsuits arising from the opioid epidemic.
Seeking to avoid potentially billions of dollars in damages, Bayer says it is again petitioning the United States Supreme Court to sharply limit legal claims that its glyphosate-based weedkiller Roundup causes cancer.
The American opioid epidemic saw deaths from prescription opioid drugs rise by a staggering 200 percent between 2000 and 2014. This didn’t just happen by accident. […]
In a major escalation of its ongoing legal and financial crisis, Bayer is reportedly preparing to settle thousands of lawsuits involving its controversial Roundup weedkiller – […]
GlaxoSmithKline & Pfizer Must Face Zantac Cancer Cases From About 75,000 Consumers in Delaware
GlaxoSmithKline, Pfizer and other drugmakers must face trials in the State court in Delaware after a judge found evidence backing up claims the companies’ former Zantac heartburn drug causes cancer to be legitimate.